on April 20 that they would sponsor a clinical trial in the US on the use of HCQ as treatment for hospitalized COVID-19 patients.
CQ was first administered at the Lung Center on March 18, and HCQ on March 25, said doctor Virginia de los Reyes, training officer at the Lung Center’s Division of Adult Pulmonology. “The use of these medications is restricted and the patients we used them with are monitored closely,” she added. The PRA has been communicating with lupus patients to get them through the pandemic without suffering the consequences of an HCQ shortage.
“The FDA appeals to the pharmacies to cater to patients with established indications of this drug. Amidst the challenges of the COVID-19 pandemic, we do not want to leave our patients who have other life threatening and debilitating diseases with nothing to use for their treatment,” they said.that they shouldn’t take CQ and HCQ to prevent the disease.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: inquirerdotnet - 🏆 3. / 86 Read more »